Human trial
NMN primary study · PMID 33888596
Postmenopausal women with prediabetes and overweight or obesity in a 10-week randomized trial.
Reported findings. The trial measured improved muscle insulin sensitivity.
Nonresponse. Nonresponse frequency not established in this excerpt.
Harms. Unknown in reviewed excerpt; absence of mention is not safety evidence.
Limits. This narrow metabolic result does not demonstrate lifespan extension or establish equivalence of other preparations.
Preparation: Source preparation; commercial equivalence unverified. Route: Unknown in reviewed excerpt; do not infer.
Read original source ↗Editorial review 2026-10-09. Clinician review pending.